PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för rosuvastatin. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

27 hits

Bibliografisk träff 2014-06-01

Achievement rates of Japan Atherosclerosis Society Guidelines 2007 LDL-cholesterol goals with rosuvastatin or atorvastatin in patients who had not achieved their goal with atorvastatin.

Shioji K, Izuhara M, Mitsuoka H, Uegaito T, Matsuda M, Kishiwada Atherosclerosis Prevention Study (KAPS) Group.

Cardiovasc Ther · comparative study; research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1111/1755-5922.12066

Bibliografisk träff 2014-04-01

Rosuvastatin can block pro-inflammatory actions of transgenic human C-reactive protein without reducing its circulating levels.

Šilhavý J, Zídek V, Landa V, Šimáková M, Mlejnek P, Škop V, Oliyarnyk O, Kazdová L, Mancini M, Saar K, Schulz H, Hübner N, Kurtz TW, Pravenec M.

Cardiovasc Ther · research support, non-u.s. gov't; journal article · DOI 10.1111/1755-5922.12061

Bibliografisk träff 2014-02-01

NLRP3 inflammasome activation in coronary artery disease: results from prospective and randomized study of treatment with atorvastatin or rosuvastatin.

Satoh M, Tabuchi T, Itoh T, Nakamura M.

Clin Sci (Lond) · comparative study; research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1042/cs20130043

Bibliografisk träff 2014-02-01

Rationale and design of the EPISTEME trial: efficacy of post-stroke intensive rosuvastatin treatment for aortogenic embolic stroke.

Ueno Y, Yamashiro K, Tanaka Y, Watanabe M, Shimada Y, Kuroki T, Miyamoto N, Daimon M, Tanaka R, Miyauchi K, Daida H, Hattori N, Urabe T.

Cardiovasc Drugs Ther · randomized controlled trial; journal article · DOI 10.1007/s10557-013-6493-6

Bibliografisk träff 2014-02-01

Anti-sympathetic action enhances statin's pleiotropic effects: the combined effect of rosuvastatin and atenolol on endothelial function.

Takase B, Hattori H, Tanaka Y, Nagata M, Ishihara M.

Int Angiol · randomized controlled trial; journal article

Bibliografisk träff 2014-01-17

Interaction of novel platelet-increasing agent eltrombopag with rosuvastatin via breast cancer resistance protein in humans.

Takeuchi K, Sugiura T, Matsubara K, Sato R, Shimizu T, Masuo Y, Horikawa M, Nakamichi N, Ishiwata N, Kato Y.

Drug Metab Dispos · research support, non-u.s. gov't; journal article · DOI 10.1124/dmd.113.054767

Bibliografisk träff 2014-01-17

Pharmacodynamic effects of atorvastatin versus rosuvastatin in coronary artery disease patients with normal platelet reactivity while on dual antiplatelet therapy--the PEARL randomized cross-over study.

Pelliccia F, Rosano G, Marazzi G, Vitale C, Spoletini I, Franzoni F, Speziale G, Polacco M, Greco C, Gaudio C.

Eur J Pharmacol · comparative study; randomized controlled trial; journal article · DOI 10.1016/j.ejphar.2014.01.006

Bibliografisk träff 2014-01-15

Rosuvastatin suppresses the oxidative response in the venous limb of an arteriovenous fistula and enhances the fistula blood flow in diabetic rats.

Fang SY, Roan JN, Lin Y, Hsu CH, Chang SW, Huang CC, Tsai YC, Lam CF.

J Vasc Res · research support, non-u.s. gov't; journal article · DOI 10.1159/000357619

Bibliografisk träff 2014-01-15

Delayed reproductive development in pubertal male rats exposed to the hypolipemiant agent rosuvastatin since prepuberty.

Leite GA, Rosa Jde L, Sanabria M, Cavariani MM, Franci JA, Pinheiro PF, Kempinas Wde G.

Reprod Toxicol · research support, non-u.s. gov't; journal article · DOI 10.1016/j.reprotox.2014.01.004

Bibliografisk träff 2014-01-01

A mechanistic framework for in vitro-in vivo extrapolation of liver membrane transporters: prediction of drug-drug interaction between rosuvastatin and cyclosporine.

Jamei M, Bajot F, Neuhoff S, Barter Z, Yang J, Rostami-Hodjegan A, Rowland-Yeo K.

Clin Pharmacokinet · research-article; journal article · DOI 10.1007/s40262-013-0097-y

Bibliografisk träff 2014-01-01

Impact of switching treatment from rosuvastatin to atorvastatin on rates of cardiovascular events.

Folse H, Sternhufvud C, Andy Schuetz C, Rengarajan B, Gandhi S.

Clin Ther · research support, non-u.s. gov't; journal article · DOI 10.1016/j.clinthera.2013.12.003

Bibliografisk träff 2014-01-01

Anti-inflammatory effects of rosuvastatin in healthy subjects: a prospective longitudinal study.

McGuire TR, Kalil AC, Dobesh PP, Klepser DG, Olsen KM.

Curr Pharm Des · clinical trial; research support, non-u.s. gov't; journal article · DOI 10.2174/1381612820666140127163313

Bibliografisk träff 2013-12-10

Rosuvastatin attenuates atherosclerosis in rats via activation of scavenger receptor class B type I.

Li Y, Wang Q, Zhou J, Xu Q, Chu X, Sun T, Liu X, Cai S.

Eur J Pharmacol · research support, non-u.s. gov't; journal article · DOI 10.1016/j.ejphar.2013.11.037

Bibliografisk träff 2013-12-09

Managing hypercholesterolemia and preventing cardiovascular events in elderly and younger Chinese adults: focus on rosuvastatin.

Wang Z, Ge J.

Clin Interv Aging · review-article; review; journal article · DOI 10.2147/cia.s41356

Bibliografisk träff 2013-11-18

Rosuvastatin treatment reduces markers of monocyte activation in HIV-infected subjects on antiretroviral therapy.

Funderburg NT, Jiang Y, Debanne SM, Storer N, Labbato D, Clagett B, Robinson J, Lederman MM, McComsey GA.

Clin Infect Dis · research-article; randomized controlled trial; journal article; research support, n.i.h., extramural · DOI 10.1093/cid/cit748

Bibliografisk träff 2013-11-09

Effect of rosuvastatin therapy on troponin I release following percutaneous coronary intervention in nonemergency patients (from the TIP 3 study).

Veselka J, Hájek P, Tomašov P, Tesař D, Brůhová H, Matějovič M, Branny M, Studenčan M, Zemánek D.

Am J Cardiol · comparative study; research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1016/j.amjcard.2013.10.026

Bibliografisk träff 2013-10-27

Effect of rosuvastatin on OX40L and PPAR-γ expression in human umbilical vein endothelial cells and atherosclerotic cerebral infarction patients.

Zhang JY, Liu B, Wang YN, Zhang WN, Wang FJ.

J Mol Neurosci · research support, non-u.s. gov't; journal article · DOI 10.1007/s12031-013-0134-1

Bibliografisk träff 2013-10-25

Evaluation of the pharmacokinetics and drug interactions of the two recently developed statins, rosuvastatin and pitavastatin.

Hu M, Tomlinson B.

Expert Opin Drug Metab Toxicol · review; journal article · DOI 10.1517/17425255.2014.851667

Bibliografisk träff 2013-10-09

Resistant nonalcoholic fatty liver disease amelioration with rosuvastatin and pioglitazone combination therapy in a patient with metabolic syndrome.

Riche DM, Fleming JW, Malinowski SS, Black CA, Miller KH, Wofford MR.

Ann Pharmacother · journal article; case reports · DOI 10.1177/1060028013507239

Bibliografisk träff 2013-10-03

A meta-analysis of randomized head-to-head trials for effects of rosuvastatin versus atorvastatin on apolipoprotein profiles.

Takagi H, Umemoto T, ALICE (All-Literature Investigation of Cardiovascular Evidence) Group.

Am J Cardiol · meta-analysis; review; journal article · DOI 10.1016/j.amjcard.2013.08.043

Bibliografisk träff 2013-09-26

Early high-dose rosuvastatin for contrast-induced nephropathy prevention in acute coronary syndrome: Results from the PRATO-ACS Study (Protective Effect of Rosuvastatin and Antiplatelet Therapy On contrast-induced acute kidney injury and myocardial damage in patients with Acute Coronary Syndrome).

Leoncini M, Toso A, Maioli M, Tropeano F, Villani S, Bellandi F.

J Am Coll Cardiol · comparative study; research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1016/j.jacc.2013.04.105

Bibliografisk träff 2013-09-26

Short-term rosuvastatin therapy for prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease.

Han Y, Zhu G, Han L, Hou F, Huang W, Liu H, Gan J, Jiang T, Li X, Wang W, Ding S, Jia S, Shen W, Wang D, Sun L, Qiu J, Wang X, Li Y, Deng J, Li J, Xu K, Xu B, Mehran R, Huo Y.

J Am Coll Cardiol · comparative study; randomized controlled trial; journal article · DOI 10.1016/j.jacc.2013.09.017

Bibliografisk träff 2013-06-24

Rosuvastatin inhibits human airway smooth muscle cells mitogenic response to eicosanoid contractile agents.

Capra V, Rovati GE.

Pulm Pharmacol Ther · research support, non-u.s. gov't; journal article · DOI 10.1016/j.pupt.2013.06.005

Bibliografisk träff 2010-01-01

Vascular damage in testicular cancer patients: a study on endothelial activation by bleomycin and cisplatin in vitro.

Nuver J, De Haas EC, Van Zweeden M, Gietema JA, Meijer C.

Oncol Rep · research support, non-u.s. gov't; journal article

Bibliografisk träff 2009-09-01

Rosuvastatin attenuates Ang II--mediated cardiomyocyte hypertrophy via inhibition of LOX-1.

Kang BY, Mehta JL.

J Cardiovasc Pharmacol Ther · research support, non-u.s. gov't; research support, u.s. gov't, non-p.h.s.; journal article · DOI 10.1177/1074248409344329

Bibliografisk träff 2008-05-28

Dose-dependent effect of rosuvastatin on VLDL-apolipoprotein C-III kinetics in the metabolic syndrome.

Ooi EM, Watts GF, Chan DC, Chen MM, Nestel PJ, Sviridov D, Barrett PH.

Diabetes Care · research support, non-u.s. gov't; research-article; randomized controlled trial; journal article; research support, n.i.h., extramural · DOI 10.2337/dc08-0358

Bibliografisk träff 2007-10-29

Vascular and neural dysfunction in Zucker diabetic fatty rats: a difficult condition to reverse.

Oltman CL, Davidson EP, Coppey LJ, Kleinschmidt TL, Lund DD, Adebara ET, Yorek MA.

Diabetes Obes Metab · research support, non-u.s. gov't; research support, u.s. gov't, non-p.h.s.; journal article; research support, n.i.h., extramural · DOI 10.1111/j.1463-1326.2007.00814.x